Australia’s National Blood Cancer Taskforce meets for first time
Monday September 30 2019
The Leukaemia Foundation established the Blood Cancer Taskforce with the support of the Federal Government to develop Australia’s first National Strategic Action Plan for Blood Cancer.
Co-chaired by Bill Petch (CEO, Leukaemia Foundation) and Professor John Seymour (Director of Cancer Medicine, Clinical Research and Haematology, Peter MacCallum Centre), the Taskforce unites Australia’s leading haematologists, researchers, patients and members of the blood cancer ecosystem for the first time. Their role is to provide a blueprint to help tackle the key issues facing the blood cancer community today and into the future.
The formation of the Taskforce and development of the Plan mark a major milestone for the blood cancer community and will set the national agenda around blood cancer for many years to come.
They met for the first time on 30 September 2019, giving them the opportunity to discuss and agree on how they will achieve the publication and distribution of the National Strategic Action Plan for Blood Cancer Plan by June 2020.
The first step will see the formation of Working Groups led by members of the Taskforce to focus on key priorities identified in the State of the Nation: Blood Cancer in Australia report. These Working Groups will engage in consultation with key blood cancer stakeholders, review existing services, programs and literature, and commence the early stages of drafting the National Strategic Action Plan for Blood Cancer.
The members of the first National Blood Cancer Taskforce are:
|Professor Sanchia Aranda AM||CEO||Cancer Council Australia|
|Dr Sharon Avery||Haematologist||Cairns Base Hospital|
|Dr John Bashford||Director of Research||Icon Group & PCPA|
|A/Professor Kate Burbury||Consultant Haematologist;
Deputy Chief Medical Officer
|Peter MacCallum Cancer Centre|
|Dr Joe Collins||Representative||Lions Club International|
|Dr Michael Dickinson||Haematologist and Disease Group Lead Aggressive Lymphoma (Peter MacCallum)||Lymphoma Australia, Chair Medical Subcommittee|
|Dr Chris Fraser||Chair Executive Council||ANZCHOG|
|Professor Maher Gandhi||CEO and Director of Clinical Research||Mater Research|
|Professor David Gottlieb||Program Director BMT, Head Cell Therapies||Westmead Hospital|
|Barbie Hartigan||Advocate||Leukaemia Foundation Patient Support|
|Professor Tim Hughes||Cancer Theme Leader||SAHMRI|
|Dr Paul Jackson||General Manager Knowledge Management||Cancer Australia|
|Professor David Joske||Chairperson||Solaris Cancer Care|
|Melanie Kelly||Director||Insight Economics|
|Dr Rishi Kotecha||Consultant Paediatric Oncologist & Clinical Haematologist||Perth Children’s Hospital; ANZCHOG|
|A/Professor Steven Lane||Head of Cancer Program||QIMR Berghofer|
|Professor Paula Marlton||Head of Leukaemia; Deputy Director Haematology||Princess Alexandra Hospital|
|Dr Robert Menz||SA&NT Council member||RACGP|
|A/Professor Peter Mollee||Director||Australasian Leukaemia & Lymphoma Group|
|Carmel O’Kane||Cancer Nurse Practitioner; Vice President & Director Professional Practice||Cancer Nurses Society of Australia|
|Bill Petch||CEO||Leukaemia Foundation|
|Professor Miles Prince AM||Director of Molecular Oncology and Cancer Immunology Epworth||Snowdome Foundation; Myeloma Australia, Epworth Hospital|
|Professor Andrew Roberts||Laboratory Head; Joint Leader, Cancer Research and Treatments Theme||Walter and Eliza Hall Institute|
|Professor John Seymour AM||Director: Department of Haematology||Peter MacCallum Cancer Centre & Royal Melbourne Hospital|
|Deborah Sims||Patient and advocate||Blood Cancer Survivor|
|Dr Delaine Smith||CEO||Australasian Leukaemia & Lymphoma Group|
|Elizabeth de Somer||CEO||Medicines Australia|
|Dr Meg Wall||Unit Head, Genetics and Molecular Pathology||Monash Pathology; Haematology Society of Australia & New Zealand|
|Dr Will Stevenson||Haematologist||Royal North Shore Hospital; Haematology Society of Australia & New Zealand|
|Richard Vines||Chairman||Rare Cancers Australia|